Gladius Capital Management LP Amneal Pharmaceuticals, Inc. Transaction History
Gladius Capital Management LP
- $166 Million
- Q3 2024
A detailed history of Gladius Capital Management LP transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Gladius Capital Management LP holds 4,390 shares of AMRX stock, worth $38,105. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,390
Previous 4,390
-0.0%
Holding current value
$38,105
Previous $36,000
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding AMRX
# of Institutions
189Shares Held
140MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$189 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$127 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$107 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$97.9 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$93.1 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.31B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...